PROK
ProKidney Corp.
1.70$
+5.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
ProKidney Corp. (PROK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -40 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.6 | -7.3 | -12 | -37 | -13 | -15 | -23 | -61 | -16 | -26 | -15 | -24 | -25 | -35 | -38 | -29 | -24 | -30 | -31 | -27 | -33 | -42 | -40 | -141 | |
| 0.3 | 0.4 | 0.5 | 0.5 | 0.6 | 0.7 | 0.8 | 0.7 | 0.8 | 0.8 | 0.9 | 1.0 | 1.1 | 1.1 | 1.3 | 1.5 | 1.6 | 1.6 | 1.5 | 1.4 | 1.8 | 1.7 | 1.7 | 6.6 | |
| 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 53 | 8.0 | 4.8 | 8.9 | 13 | 11 | 13 | -6.4 | 7.7 | 7.8 | 6.9 | 6.9 | 6.4 | 6.5 | 6.7 | 5.7 | 4.9 | 5.6 | 23 | |
| 0.2 | 0.2 | 0.2 | – | 0.2 | 54 | 8.0 | 66 | 8.9 | 13 | -16 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.2 | 3.8 | 0.2 | 2.3 | -0.1 | -1.4 | -9.6 | -12 | -0.9 | -2.4 | 9.3 | 5.9 | 3.9 | -5.8 | -7.5 | -0.3 | 18 | 1.1 | -1.9 | 1.3 | 0.8 | -5.3 | 7.7 | 4.5 | |
| 2.5 | 1.4 | 2.0 | 4.7 | 0.5 | 0.8 | 0.4 | 1.5 | 0.3 | 1.0 | 3.7 | 28 | 1.6 | 1.0 | 0.6 | 2.4 | 26 | 1.1 | 3.1 | 5.2 | 5.8 | 3.8 | 3.8 | 19 | |
| -2.5 | -1.4 | -2.0 | -4.7 | -0.5 | -0.8 | -0.4 | -1.4 | -0.3 | -193 | -13 | -28 | -96 | 58 | 29 | -82 | 15 | 28 | 19 | 29 | 28 | 35 | 13 | 105 | |
| – | – | – | – | – | – | – | 543 | – | – | – | – | -9.5 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | – | 0.0 | 20 | 0.3 | -0.3 | 0.0 | 0.0 | 0.0 | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 20 | 10.0 | 41 | 30 | 26 | 15 | 548 | 0.0 | 0.0 | 0.0 | 0.0 | -9.5 | 0.0 | 140 | 4.5 | 0.1 | 0.0 | 0.0 | 8.0 | 18 | 0.2 | 0.5 | 26 | |
| 4.6 | 11 | -3.9 | 0.3 | 20 | 9.2 | -7.9 | 506 | -16 | -219 | -28 | -52 | -131 | 24 | 130 | -106 | -9.0 | -1.3 | -13 | 10 | 13 | -6.6 | -27 | -10 | |
| -10 | -8.6 | -14 | -42 | -14 | -16 | -23 | -62 | -16 | -27 | -19 | -52 | -27 | -36 | -39 | -32 | -50 | -31 | -35 | -32 | -38 | -45 | -44 | -160 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.